Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • John Acquavella
  • Vera Ehrenstein
  • Morten Schiødt, Department of Oral and Maxillofacial Surgery, Rigshospitalet, Copenhagen, Denmark.,
  • Uffe Heide-Jørgensen
  • Anders Kjellman, Department of Urology, Karolinska University Hospital; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden., Svein Hansen, Department of Paediatrics, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Norwegian Cancer Registry, Oslo, Norway., Cecilia Larsson Wexell, University of Gothenburg, Bente Brokstad Herlofson, Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.,
  • Sven Erik Noerholt
  • Haijun Ma, Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA, USA., Katarina Öhrling, Clinical Development, Amgen Inc., Thousand Oaks, CA, USA., Rohini K Hernandez, Center for Observational Research, Amgen Inc., One Amgen Center Drive, MS 24-2-A, Thousand Oaks, CA 91320, USA. Electronic address: karynsah@amgen.com.,
  • Henrik Toft Sørensen
Original languageEnglish
JournalClinical epidemiology
Volume8
Pages (from-to)267-72
Number of pages6
ISSN1179-1349
DOIs
StatePublished - 2016

    Research areas

  • Journal Article

See relations at Aarhus University Citationformats

ID: 103761742